MedTrace Logo

Open-trial on the Prevention of Chronic Migraines With the CEFALY Device

NCT02342743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2019-06-20

Study results available
· View outcomes & findings →

Summary

The main objective of this study was to assess the safety and efficacy of the Cefaly® e-TNS device as a prophylactic treatment of chronic migraine in adult patients.

Conditions

Interventions

DEVICE

CEFALY

Sponsors & Collaborators

  • Cefaly Technology

    lead INDUSTRY

Principal Investigators

  • Marius Birlea, MD · Department of Neurology, University of Colorado Anschutz Medical Campus

  • Pierre Rigaux · Cefaly Technology

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-02
Primary Completion
2017-04-11
Completion
2017-04-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342743 on ClinicalTrials.gov